1-6 of 6
Sara Ghorashian
Close
Sort by
Journal Articles

Risk of T-cell malignancy after CAR T-cell therapy in children, adolescents, and young adults

Adam J. Lamble, Liora M. Schultz, Khanh Nguyen, Emily M. Hsieh, Kevin McNerney, Rayne H. Rouce, Rebecca A. Gardner, Sara Ghorashian, Nirali N. Shah, Shannon L. Maude
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3544–3548.
https://doi.org/10.1182/bloodadvances.2024013243
Published: 2024
Journal Articles

Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy

Maria Gabelli, Macarena Oporto-Espuelas, Saskia Burridge, Jan Chu, Susan Farish, Emma Hedges, Kirsty Ware, Lindsey Williams, Lindsey Young, Rajesh Alajangi, Philip Ancliff, Jack Bartram, Denise Bonney, Lenka Chenchara, Robert Chiesa, Chiara Cugno, Katharine Hodby, Katarzyna A. Jalowiec, Arina Lazareva, Giovanna Lucchini, Oana C. Mirci-Danicar, Khushnuma Mullanfiroze, Vesna Pavasovic, Anupama Rao, Kanchan Rao, Lynne Riley, Sujith Samarasinghe, Geoff Shenton, Juliana Silva, Ajay Vora, Rachael Hough, Persis J. Amrolia, Sara Ghorashian
Journal: Blood Advances
Blood Adv (2024) 8 (8): 1959–1963.
https://doi.org/10.1182/bloodadvances.2023011168
Published: 2024
Includes: Supplemental data
Journal Articles

Activation priming and cytokine polyfunctionality modulate the enhanced functionality of low-affinity CD19 CAR T cells

Ilaria M. Michelozzi, Eduardo Gomez-Castaneda, Ruben V. C. Pohle, Ferran Cardoso Rodriguez, Jahangir Sufi, Pau Puigdevall Costa, Meera Subramaniyam, Efstratios Kirtsios, Ayad Eddaoudi, Si Wei Wu, Aleks Guvenel, Jonathan Fisher, Sara Ghorashian, Martin A. Pule, Christopher J. Tape, Sergi Castellano, Persis J. Amrolia, Alice Giustacchini
Journal: Blood Advances
Blood Adv (2023) 7 (9): 1725–1738.
https://doi.org/10.1182/bloodadvances.2022008490
Published: 2023
Includes: Supplemental data
Journal Articles

CD34 + -selected stem cell boost can safely improve cytopenias following CAR T-cell therapy

Khushnuma Mullanfiroze, Arina Lazareva, Jan Chu, Lindsey Williams, Saskia Burridge, Juliana Silva, Robert Chiesa, Kanchan Rao, Giovanna Lucchini, Sara Ghorashian, Maeve O’Reilly, Ben Carpenter, Victoria Grandage, Rachael Hough, Claire Roddie, Persis J. Amrolia
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4715–4718.
https://doi.org/10.1182/bloodadvances.2022007572
Published: 2022
Journal Articles

Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiency

Clinical Trials & Observations
Sandheeah Ramdeny, Asima Chaudhary, Austen Worth, Sara Ghorashian, Mary Slatter, Su Han Lum, Ajay Vora
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2153–2155.
https://doi.org/10.1182/bloodadvances.2021004284
Published: 2021
Journal Articles

CD1a is rarely expressed in pediatric or adult relapsed/refractory T-ALL: implications for immunotherapy

Sarah Leong, Sarah Inglott, Foteini Papaleonidopoulou, Karen Orfinada, Philip Ancliff, Jack Bartram, Ben Carpenter, Adele K. Fielding, Sara Ghorashian, Victoria Grandage, Rajeev Gupta, Rachael Hough, Asim Khwaja, Vesna Pavasovic, Anupama Rao, Sujith Samarasinghe, Ajay Vora, Marc R. Mansour, David O’Connor
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4665–4668.
https://doi.org/10.1182/bloodadvances.2020002502
Published: 2020
Includes: Supplemental data